This website uses cookies to ensure you have the best experience. Learn more

Indian Pharma Essay

9542 words - 39 pages

Pharmaceutical and Medical Products Practice

India Pharma 2020
Propelling access and acceptance, realising true potential

The report is furnished to the recipient for information purposes only. Each recipient should conduct its own investigation and analysis of any such information contained in this report. No recipient is entitled to rely on the work of McKinsey & Company, Inc. contained in this report for any purpose. McKinsey & Company, Inc. makes no representations or warranties regarding the accuracy or completeness of such information and expressly disclaims any and all liabilities based on such information or on omissions therefrom. The recipient must not reproduce, disclose ...view middle of the document...

The total market for healthcare products and services had grown at a compounded annual growth rate of 14 per cent from 2000 to 2005. The pharmaceutical industry had grown at a compounded annual growth rate of 9 per cent during that period. We felt in 2007 that the Indian pharmaceutical market was poised for a clear and discernable step-up in its growth trajectory. In our earlier report, India Pharma 2015 – Unlocking the Potential of the Indian Pharmaceutical Market, we projected that the market would grow at a compounded annual growth rate of 12 to 14 per cent to become a USD 20 billion to USD 24 billion market by 2015. This growth would be driven primarily by rising incomes, and be supported by five other factors: enhanced medical infrastructure; rise in the prevalence and treatment of chronic diseases; greater health insurance coverage; launches of patented products; and new market creation in existing white spaces. These factors are now bearing fruit, and market growth has kept pace with projections. Various industry reports suggest that the industry has been growing at 13 to 14 per cent over the last 5 years—a sharp rise from the 9 per cent compounded annual growth rate between 2000 and 2005. Most of the growth drivers have kept pace with expectations (Exhibit 1). India’s GDP from 2005 to 2009 grew at about 8 per cent. Growth in medical infrastructure and health insurance coverage has been in line with expectations. The treatment of chronic diseases has gone up. The remarkable success of a few recent launches has demonstrated the true potential of patented products.

14

Exhibit 1

Growth in input drivers in line with expectations1 in most cases
Growth in income level Real GDP growth Per cent, 2005-2009
7.3 7.9

Growth in medical infrastructure No. of doctors in India Thousands, 2009 ~780-800 760

Expected

Actual

Expected

Actual

Increase in health insurance coverage No. of people covered by insurance Millions, 2010
300

Rise in prevalence of disease Prevalence rate for diabetes in India Per cent
2.8 3.5

~150 Expected Actual2

2005

2010

1 Based on estimates made in India Pharma 2015 – Unlocking the potential of the Indian pharmaceuticals market 2 The steep rise in insurance coverage is due to government sponsored coverage for below poverty line (BPL) population. This possibility was highlighted in our previous report, though not included in projected estimates SOURCE: Global Insight; National Commission on Macroeconomics and Health - Burden of Disease in India; Medical Council of India; secondary research

While the market has gained in confidence, it is also facing a period of flux. First, the broader healthcare sector is experiencing discontinuous development. Manifold rise in public healthcare spending, rising patient awareness, expanding insurance coverage across the income pyramid and the emergence of new hospital formats illustrates this flux. Second, in the past 3 to 4 years, industry structure...

Other Papers Like Indian Pharma

Esops-Project Report

1742 words - 7 pages The sector overview and Major players The Indian Pharmaceutical industry is highly fragmented with about 24,000 players (around 330 in the organised sector). The top ten companies make up for more than a third of the market. The Indian pharma industry (IPM) grew by 16% YoY in 2012 to ` 629 bn. It accounts for about 1.4% of the world's pharma industry in value terms and 10% in volume terms. Besides the domestic market, Indian pharma companies

Pharma Companies in India Essay

747 words - 3 pages urbanisation. Diagnostics Outsourcing/Clinical Trials According to the research published by RNCOS titled 'Indian Diagnostic Market Analysis' published in January 2010, the Indian diagnostic services are projected to grow at a CAGR of more than 20 per cent during 2010-2012. Some of the major Indian pharmaceutical firms, including Sun Pharma, Cadilla Healthcare and Piramal Life Sciences, had applied for conducting clinical trials on at least 12 new

Financial Analysis Gsk

3871 words - 16 pages in India, located at Nashik and Thane as well as a clinical development centre in Bangalore. The state of art plant at Nashik makes formulations while bulk drugs and the active pharmaceutical ingredients are manufactured at Thane. 2 The Indian Pharmaceutical industry The Pharmaceutical industry in India is the world's third-largest in terms of volume and stands 14th in terms of value. The Indian pharma industry is today, the third largest

Production and Operation of Vifor Pharma Privated Limited

3414 words - 14 pages GROWTH RATE The Pharma industry in India is a $ 10 billion industry, growing at a rate of 8-9% annually. The output of Indian pharmaceutical industry ranks 4th in terms of volume and 13th in terms of value and around 8% of the world’s drugs are manufactured in India. 1.3 SIZE India has 300 Pharma companies of large and moderate size and another 10,000 small and tiny firms. But 70% of the production is by the

Itm. Piramal Healthcare

1232 words - 5 pages since 1988. Piramal Healthcare had consolidated revenues of THEM$ 656 million in FY2009. PHL is currently ranked 4th in the Indian market with a diverse product portfolio spanning several therapeutic areas. It is also one of the largest custom manufacturing companies with a global footprint of assets across North America, Europe and Asia. VISION AND VALUES They believe they can create value only if they care for the ones they serve

India Pharmaceutical Cluster

9670 words - 39 pages ................................................................................................................................ 22 Select Pharmaceutical Companies in Andhra Pradesh ............................................................... 22 Dr Reddy's Laboratories Ltd ............................................................................................... 22 Aurobindo Pharma Ltd. ...................................................................................................... 23 Indian Drugs and Pharmaceutical Limited

Big Pharma: Suppression of a Cure for Caner

1418 words - 6 pages their facilities. Big Pharma (the nickname given to large pharmaceutical companies) is suppressing the cure for cancer because cancer makes these corporations money. The often natural and inexpensive methods of curing cancer proposed are a threat to the capital generated by the treatment of the disease. If a simple and natural cure was discovered, the whole industry would crumble. The companies that make up the pharmaceutical industry are

Foreign Direct Investment

2538 words - 11 pages in mobile e-commerce through obtaining DoCoMo’s technology (Rasiah, Gammeltoft, & Yang, 2010). Since 1992, Indian OFDI has pursued technology as an important target in developed countries. Indian MNCs have also been active in takeovers in Europe. For example, Lupin entered into an agreement with Belgium’s Artifex Finance to acquire a 51 percent majority stake in Dafra Pharma giving the Indian firm access to 25 African countries and Dr Reddy’s

Economics

5387 words - 22 pages Global competitiveness of Indian industry Contents Global competitiveness of Indian industry 1 Introduction :- 1 Systemic Process of Innovation :- 1 Innovative strategy for Indian Business for the future :- 2 Quality :- 2 Innovation :- 2 Customer - Commitment :- 3 Change acceptance :- 3 Globalization :- 3 Marketing Innovation :- 3 Global competitiveness of Pharmaceutical Industry: 4 Introduction 4 Evolution of Indian

Case Study

1805 words - 8 pages |   | 1982 |   | | • Brar become GM for 2 divisions (Animal Healthcare & International) | | | | | | | | | | • Ranbaxy turnover reaches 360 million | | | | | • Market Capitalization reaches 35 million | | | | | | | | | | | | 1986 |   | • Brar becomes GM of Pharma (Head) & also takes charge of chemicals division | | |   | | | • 2 Family Bhai Manjit Singh & Analjit Singh leaves the Co. |   | 1989

Export Procedures in Pharma

2159 words - 9 pages characteristic of the Indian pharmaceutical market as the industry is highly fragmented. Market Size The Indian pharma industry, which is expected to grow over 15 per cent per annum between 2015 and 2020, will outperform the global pharma industry, which is set to grow at an annual rate of 5 per cent between the same period##.The market is expected to grow to US$ 55 billion by 2020, thereby emerging as the sixth largest pharmaceutical market

Related Essays

Indian Pharma Essay

1257 words - 6 pages , in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously.  Playing a key role in promoting and sustaining development in the vital field of medicines, Indian Pharma Industry boasts of quality producers and many units approved by regulatory authorities in USA and UK. International companies

Indian Pharma Industry Essay

1993 words - 8 pages Indian Pharma Industry – an overview April 13, 2012 The demand for pharmaceutical products in India is significant and is driven by low drug penetration, rising middle-class & disposable income, increased government & private spending on healthcare infrastructure, increasing medical insurance penetration etc.    The Indian pharmaceutical industry is growing at about 8 to 9 percent annually according to “A Brief Report Pharmaceutical

Impact Of Tqm On Indian Pharma Industry Synopsis

3789 words - 16 pages pharmaceutical companies across India. O4: To analyze the performance of Indian pharmaceutical Industries and compare with some major global pharma industries. T1: The performance of Indian Pharmaceutical Industry will be analyzed for financial performance, product quality, customer satisfaction, employee satisfaction, Market performance, Business results, cost and waste reductions, safety aspects. T2: The above parameters will be compared with

Muscovite Powder Mill Manufacturers Essay

574 words - 3 pages Prism Pharma Machinery , Pharmaceuticals Machinery,Pharma Welcome. Prism Pharma Machinery , Pharmaceuticals Machinery,Pharma Machines Manufacturer, Manufacturers & Exporters of Pharmaceutical Machinery Food Processing Machines - Oil Processing Machines, Food Exporters and manufacturers of food processing machines, oil processing machines, oil mill machinery, oil extraction machinery, seed cleaning machine, seed cleaning Guidance for